Lyrica CR (Parke-Davis Div of Pfizer Inc)
Welcome to the PulseAid listing for the Lyrica CR drug offered from Parke-Davis Div of Pfizer Inc. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Parke-Davis Div of Pfizer Inc |
NON-PROPRIETARY NAME: | PREGABALIN |
SUBSTANCE NAME: | PREGABALIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-01-01 |
END MARKETING DATE: | 0000-00-00 |
Lyrica CR HUMAN PRESCRIPTION DRUG Details:
Item Description | Lyrica CR from Parke-Davis Div of Pfizer Inc |
LABELER NAME: | Parke-Davis Div of Pfizer Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 165(mg/1) |
START MARKETING DATE: | 2016-01-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0071-1027_baef57a9-34f3-40a5-831f-d71c195f2439 |
PRODUCT NDC: | 0071-1027 |
APPLICATION NUMBER: | NDA021446 |
Other PREGABALIN Pharmaceutical Manufacturers / Labelers: